Total revenues of $6.8 billion (Q1 2024: $6.5 billion) were 3 % ahead as contributions from acquisitions and strong commercial management more than offset the impact of divestitures and lower activity levels due to adverse weather in many regions.
Net loss of 98 million USD (Q1 2024 net income: 114 million USD) was behind the prior year.
Adjusted EBITDA of 495 million USD (Q1 2024: 445 million USD) was 11 % ahead as a result of the continued delivery of CRH's differentiated strategy, positive pricing, ongoing cost control and further operational efficiencies.
CRH's net loss margin of 1.5 % was behind Q1 2024 (Q1 2024 net income margin: 1.7 %), while Adjusted EBITDA margin of 7.3 % (Q1 2024: 6.8 %) was ahead of the comparable prior year period. Diluted (loss) earnings per share for Q1 2025 was 0.15 USD (Q1 2024: 0.16 USD).
